Stocks and Investing Stocks and Investing
Fri, August 4, 2023

Maury Raycroft Upgraded (BCRX) to Strong Buy and Held Target at $11 on, Aug 4th, 2023


Published on 2024-10-28 05:33:44 - WOPRAI, Maury Raycroft
  Print publication without navigation


Maury Raycroft of Jefferies, Upgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Strong Buy and Held Target at $11 on, Aug 4th, 2023.

Maury has made no other calls on BCRX in the last 4 months.



There are 3 other peers that have a rating on BCRX. Out of the 3 peers that are also analyzing BCRX, 0 agree with Maury's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Maury


  • Serge Belanger of "Needham" Reiterated at Strong Buy with Decreased Target to $12 on, Thursday, August 3rd, 2023
  • Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Held Target at $10 on, Thursday, July 13th, 2023
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy with Decreased Target to $10 on, Thursday, April 20th, 2023

Contributing Sources